0.6184
1.23%
-0.0077
After Hours:
.62
0.0016
+0.26%
Painreform Ltd stock is traded at $0.6184, with a volume of 104.44K.
It is down -1.23% in the last 24 hours and down -53.78% over the past month.
See More
Previous Close:
$0.6261
Open:
$0.6449
24h Volume:
104.44K
Relative Volume:
0.28
Market Cap:
$703.80K
Revenue:
-
Net Income/Loss:
$-9.34M
P/E Ratio:
-0.0681
EPS:
-9.0833
Net Cash Flow:
$-6.69M
1W Performance:
-0.26%
1M Performance:
-53.78%
6M Performance:
-94.34%
1Y Performance:
-97.04%
Painreform Ltd Stock (PRFX) Company Profile
Painreform Ltd Stock (PRFX) Latest News
Prestige Wealth Inc. (NASDAQ:PWM) Sees Significant Drop in Short Interest - Defense World
PainReform Ltd. (NASDAQ:PRFX) Short Interest Up 2,221.4% in September - Defense World
Insider’s View: Deciphering PainReform Ltd (PRFX)’s Financial Health Through Ratios - The Dwinnex
US Stocks Edge Higher; Chicago Fed National Activity Increases In August - Benzinga
PainReform Ltd (PRFX)’s results reveal risk - US Post News
Why Granite Point Mortgage Trust Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
PainReform Ltd [PRFX] Is Currently 4.40 below its 200 Period Moving Avg: What Does This Mean? - The DBT News
Was there any good news for PainReform Ltd (PRFX) stock in the last session? - US Post News
Navigating PRFX’s Stock Market Maze: Ups and Downs in 2023 - The InvestChronicle
PRFX stock touches 52-week low at $0.74 amid sharp annual decline - Investing.com
Financial Health Check: Examining PainReform Ltd (PRFX)’s Key Ratios - The Dwinnex
United States shares mixed at close of trade; Dow Jones Industrial Average down 0.23% - MSN
U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.23% - MSN
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.23% - MSN
PainReform Ltd. Confirms Sutures Compatibility in Human Clinical Trials for PRF-110 - GlobeNewswire
PainReform Ltd. Launches Warrant Exercise Incentive Program - TipRanks
PainReform confirms sutures compatibility for in trial for PRF-110 - TipRanks
PainReform Ltd. Confirms Sutures Compatibility in Human Clinical Trials for PRF-110 - Yahoo Finance
Ratio Analysis: Unpacking PainReform Ltd (PRFX)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
PainReform to issue new warrants in stock exercise deal By Investing.com - Investing.com Australia
United States shares mixed at close of trade; Dow Jones Industrial Average down 0.23% - Investing.com India
PRFX stock touches 52-week low at $1.17 amid steep annual decline - Investing.com India
PainReform Shares Are Trading Lower Today: What's Going On - Benzinga
PRFX stock touches 52-week low at $1.17 amid steep annual decline - Investing.com
PRFX stock touches 52-week low at $1.17 amid steep annual decline - Investing.com UK
PainReform to issue new warrants in stock exercise deal - Investing.com
PainReform to issue new warrants in stock exercise deal By Investing.com - Investing.com Canada
PainReform to issue new warrants in stock exercise deal By Investing.com - Investing.com UK
PainReform Announces Exercise of Warrants for $1.58 Million Gross Proceeds - GlobeNewswire
PainReform Announces Exercise of Warrants for $1.58 Million Gross Proceeds - StockTitan
Holdings of PainReform Ltd (PRFX) are aligned with the stars - SETE News
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.23% - Investing.com
PainReform Ltd [PRFX] is -90.64% lower this YTD. Is it still time to buy? - The DBT News
Upcoming Stock Splits This Week (September 9 to September 13) – Stay InvestingTHE BHARAT EXPRESS NEWS - The Bharat Express News
PainReform Ltd: Navigating Market Volatility with a 1.79 Debt-to-Equity Ratio - The InvestChronicle
PainReform Ltd (PRFX) stock analysis: A simple moving average approach - US Post News
Upcoming Stock Splits This Week (September 9 to September 13) – Stay Invested - Yahoo Finance
PainReform Ltd’s Mixed Bag: Down -90.20% in 6 Months, Down -38.34% in 30 Days - The InvestChronicle
PainReform Announces Reverse Share Split - TipRanks
Market Momentum: PainReform Ltd (PRFX) Registers a -4.21 Decrease, Closing at 0.22 - The Dwinnex
PainReform (NASDAQ:PRFX) Shares Down 11.7% - Defense World
PRFX stock touches 52-week low at $0.24 amid sharp annual decline - Investing.com
Market Insight: PainReform Ltd (PRFX)’s Notable Gain, Closing at 0.27 - The Dwinnex
The time has not yet come to remove your chips from the table: PainReform Ltd (PRFX) - SETE News
PainReform Ltd. Schedules 2024 Annual Meeting - TipRanks
Do investors need to be concerned about PainReform Ltd (PRFX)? - US Post News
Prepare Yourself for Liftoff: PainReform Ltd (PRFX) - SETE News
PainReform reports breakthrough in post-surgical pain management - Investing.com India
PainReform reports breakthrough in post-surgical pain management - Investing.com
PainReform Bunionectomy Study Observations Confirm Optimal Delivery Method for PRF-110 in Bunionectomy Procedures - Yahoo Finance
PainReform Bunionectomy Study Observations Confirm Optimal - GlobeNewswire
Painreform Ltd Stock (PRFX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):